Opens in a new tab

Scientific and Technical Writing Services for Biotech and Pharma

Syner-G BioPharma delivers submission-ready, scientifically accurate documentation aligned with FDA, EMA, and ICH guidelines. Our regulatory-grade scientific and technical writing services support pharma, biotech, medical device, and CRO or CDMO teams at every development stage.

Operating globally since 2007, our full-time scientific experts function as embedded strategic partners. That model drives a client retention rate exceeding 90%.

Phase-Appropriate Deliverables for Every Stage of Development

Our writing support scales with your program, from emerging biotech discovery through large pharma commercialization. For broader documentation needs, our core medical writing solutions serve as a centralized resource for your global portfolio.

Our scientific and technical writing solutions cover key development milestones, delivering:

Clinical and regulatory documents, including protocols, clinical study reports (CSRs), and safety summaries

Regulatory submission content optimized to meet CTD module expectations

Chemistry, manufacturing, and controls (CMC) documentation requiring precise scientific terminology

Writers work directly with in-house experts to align every document with your broader regulatory strategy. Ready to outline your program requirements?

A Structured Workflow Engineered for Lean Biopharma Teams

Our scientific and technical writing services run on a structured delivery model managed entirely by permanent staff. The full-time employee model eliminates contractor fatigue and the constant need for re-onboarding, giving lean sponsor teams reliable project continuity.

We manage every engagement through a defined workflow covering alignment on purpose, source document collection, content plan approval, drafting, structured reviews, and version control. For delivery predictability under tight milestones, we establish clear collaboration norms through scheduled meetings, standard review cadences, and centralized decision logs.

That operational discipline is why our client retention rate exceeds 90 percent.

Independent Quality Control Engineered for Audit Readiness

Audit-ready documents require quality control that operates as an independent phase, separate from authorship.

  • The writer drafts the document and completes an initial self-check.
  • An independent QC specialist conducts 100% source-data verification, checking all tables, figures, and scientific statements against validated source outputs.
  • The specialist checks formatting and template consistency, resolving all findings before final publishing.

This rigorous process calls on our dedicated QC capability and reduces the risk of document inconsistencies that can trigger regulatory questions or filing deficiencies.

Secure Integration with Sponsor Document Systems

Our technical and scientific writing solutions integrate directly with your designated Electronic Document Management System (EDMS), such as Veeva Vault, to maintain strict version control. Operating under your SOPs via sponsor-provisioned accounts, role-based permissions, and controlled templates eliminates unmanaged email attachments while preserving audit trails for inspection readiness.

This secure environment moves documentation from draft to approval, enabling a clean handoff to our electronic publishing and technical writing specialists. Maintaining files in your native platform preserves compliant formatting and accelerates submission timelines.

Frequently Asked Questions

We offer project-based milestones or monthly retainers for cost predictability. Primary cost drivers include document complexity, raw data readiness, and required review cycles.

Clinical study reports typically require six to eight weeks. Complex marketing modules range from ten to sixteen weeks. Timelines vary based on database lock readiness and sponsor review latency.

Our dedicated QC services team performs 100% source-data verification as an independent step. We cross-check every figure, table, and claim against raw outputs before submission delivery.

Our full-time writers operate within sponsor-provisioned accounts, such as Veeva Vault. We strictly adhere to your internal templates, style guides, and SOPs across all of our clinical medical writing solutions.

We draft modules that satisfy FDA, EMA, and PMDA expectations. Our writers frame your data to support a global regulatory strategy across multiple markets.

We do not use Generative AI to draft clinical narrative text, preserving strict data confidentiality and intellectual property provenance. All content is authored and verified by human experts.

Ready to align on resource planning for your next regulatory milestone?

Get Started Now